The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 27, 2016
Filed:
Mar. 03, 2014
Amylin Pharmaceuticals, Llc, San Diego, CA (US);
Astrazeneca Pharmaceuticals Lp, Wilmington, DE (US);
Odile Esther Levy, San Diego, CA (US);
Michael R. Hanley, Corte Madera, CA (US);
Carolyn M. Jodka, Encinitas, CA (US);
Diana Y. Lewis, San Diego, CA (US);
Christopher J. Soares, La Jolla, CA (US);
Soumitra S. Ghosh, San Diego, CA (US);
Lawrence J. D'Souza, San Diego, CA (US);
David G. Parkes, Del Mar, CA (US);
Christine M. Mack, Camarillo, CA (US);
Amylin Pharmaceuticals, LLC., San Diego, CA (US);
AstraZeneca Pharmaceuticals LP, Wilmington, DE (US);
Abstract
The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-related conditions. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes.